{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:47Z","timestamp":1788922127664,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["KFJJ-2024-04"],"award-info":[{"award-number":["KFJJ-2024-04"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003472","name":"Harbin Institute of Technology","doi-asserted-by":"publisher","award":["ES202409"],"award-info":[{"award-number":["ES202409"]}],"id":[{"id":"10.13039\/501100003472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011382","name":"State Key Laboratory of Urban Water Resource and Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071261"],"award-info":[{"award-number":["32071261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMKF202506"],"award-info":[{"award-number":["SKLNMKF202506"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuroscience.2025.12.023","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:29:08Z","timestamp":1765592948000},"page":"226-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel hybrid peptide BNT12 displays potent antinociception with limited opioid-like side effects at the spinal level"],"prefix":"10.1016","volume":"593","author":[{"given":"Si-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ren","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Yun","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7104-3822","authenticated-orcid":false,"given":"Che","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.12.023_b0005","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1021\/jm050921q","article-title":"Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors","volume":"49","author":"Agnes","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2004.02.023","article-title":"Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties","volume":"488","author":"Bonney","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(83)92028-7","article-title":"Neurotensin stimulates defaecation","volume":"1","author":"Calam","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2022.109778","article-title":"High-frequency ultrasound-guided intrathecal injections in a young mouse model: Targeting the central nervous system in drug delivery","volume":"386","author":"Choi","year":"2023","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0035","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","article-title":"Perioperative opioid analgesia-when is enough too much? a review of opioid-induced tolerance and hyperalgesia","volume":"393","author":"Colvin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2019.03.006","article-title":"Bifunctional opioid receptor ligands as novel analgesics","volume":"151","author":"Cunningham","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0045","doi-asserted-by":"crossref","first-page":"38746","DOI":"10.1038\/srep38746","article-title":"Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord","volume":"6","author":"Dai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0050","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1021\/acsptsci.4c00236","article-title":"Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics","volume":"7","author":"De Neve","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0055","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1021\/acs.jmedchem.4c00442","article-title":"Multitarget \u03bc-opioid receptor agonists\u2500neuropeptide FF receptor antagonists induce potent antinociception with reduced adverse side effects","volume":"67","author":"De Neve","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1523\/JNEUROSCI.19-01-00503.1999","article-title":"Identification of the receptor subtype involved in the analgesic effect of neurotensin","volume":"19","author":"Dubuc","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejmech.2019.05.037","article-title":"Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors","volume":"178","author":"Dvor\u00e1csk\u00f3","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2019.01.048","article-title":"The combination of opioid and neurotensin receptor agonists improves their analgesic\/adverse effect ratio","volume":"848","author":"Eiselt","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0075","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The Role of Opioid Receptors in Immune System Function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/1381612820666141027124915","article-title":"The roles of neurotensin and its analogues in pain","volume":"21","author":"Feng","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2024.01.045","article-title":"Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments","volume":"166","author":"Ford","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0090","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.apsb.2020.04.014","article-title":"Novel opioid-neurotensin-based hybrid peptide with spinal long-lasting antinociceptive activity and a propensity to delay tolerance development","volume":"10","author":"Fr\u0105czek","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","article-title":"Transition from acute to chronic pain after surgery","volume":"393","author":"Glare","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0100","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1021\/acs.jmedchem.0c01376","article-title":"Optimized opioid-neurotensin multitarget peptides: from design to structure-activity relationship studies","volume":"63","author":"Gonzalez","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1432-1033.1982.tb05913.x","article-title":"Synthesis and characterization of neurotensin analogues for structure\/activity relationship studies. Acetyl-neurotensin-(8\u201313) is the shortest analogue with full binding and pharmacological activities","volume":"124","author":"Granier","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0110","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.cell.2025.04.038","article-title":"Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain","volume":"188","author":"Guo","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.04.024","article-title":"Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain","volume":"1395","author":"Hanlon","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0120","article-title":"Histochemical analysis of the biphasic properties of formalin pain-induced behavior","volume":"34","author":"Hirota","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0145","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1460-9568.2006.05151.x","article-title":"Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons","volume":"24","author":"Jomphe","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2024.100172","article-title":"Neurotensin-expressing lateral hypothalamic neurons alleviate neuropathic and inflammatory pain via neurotensin receptor signaling","volume":"16","author":"Khan","year":"2024","journal-title":"Neurobiol. Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1744-8069-6-86","article-title":"PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects","volume":"6","author":"Kleczkowska","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2013.03.004","article-title":"Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation\u2013a review","volume":"716","author":"Kleczkowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.11.007","article-title":"Neurokinin-1 receptor-based bivalent drugs in pain management: the journey to nowhere?","volume":"196","author":"Kleczkowska","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejps.2016.04.014","article-title":"Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - a comparison with morphine","volume":"89","author":"Lesniak","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(98)00340-9","article-title":"Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice","volume":"352","author":"Matsumoto","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-3057(85)90376-4","article-title":"Motor hypoactivity induced by neurotensin and related peptides in mice","volume":"22","author":"Meisenberg","year":"1985","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/08923973.2022.2037628","article-title":"Neurotensin agonist PD 149163 modulates the neuroinflammation induced by bacterial endotoxin lipopolysaccharide in mice model","volume":"44","author":"Mishra","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14925","article-title":"The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model","volume":"36","author":"Nozu","year":"2024","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jnr.25199","article-title":"Microglial inflammation modulates opioid analgesic tolerance","volume":"101","author":"Pahan","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejps.2015.11.015","article-title":"Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain","volume":"82","author":"Papathanasiou","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0215","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1097\/j.pain.0000000000001050","article-title":"Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice","volume":"158","author":"Peterson","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3829472","article-title":"Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners","volume":"2017","author":"Popiolek-Barczyk","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0225","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.3390\/ijms222111347","article-title":"Biphalin-a Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?","volume":"22","author":"Redkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav9946","article-title":"Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain","volume":"5","author":"Richner","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0235","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1471-4159.2007.05205.x","article-title":"Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model","volume":"105","author":"Roussy","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0240","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.3390\/ijms20235935","article-title":"Endomorphin-2- and Neurotensin- based Chimeric Peptide Attenuates Airway Inflammation in Mouse Model of Nonallergic Asthma","volume":"20","author":"Russjan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0245","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1523\/JNEUROSCI.0810-05.2005","article-title":"Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors","volume":"25","author":"Sarret","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00770","article-title":"Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems","volume":"22","author":"Sharma","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1067\/S1526-5900(03)00781-8","article-title":"Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis","volume":"4","author":"Shields","year":"2003","journal-title":"J. Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0260","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cell.2020.04.053","article-title":"\u03b2-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors","volume":"181","author":"Slosky","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0265","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2018.02.002","article-title":"Visceral pain - Novel approaches for optogenetic control of spinal afferents","volume":"1693","author":"Spencer","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108232","article-title":"Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain","volume":"178","author":"Starnowska-Sok\u00f3\u0142","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(97)81698-8","article-title":"Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats","volume":"774","author":"Stiller","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173174","article-title":"Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog","volume":"882","author":"T\u00e9treault","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuropharm.2014.05.046","article-title":"Activation of neurotensin receptor type 1 attenuates locomotor activity","volume":"85","author":"Vadnie","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bpa.2023.02.003","article-title":"Intrathecal drug delivery in the management of chronic pain","volume":"37","author":"Van Zundert","year":"2023","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2016.12.026","article-title":"Endomorphin-2 analogs with C-terminal esterification produce potent systemic antinociception with reduced tolerance and gastrointestinal side effects","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0305","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1213\/ANE.0000000000002318","article-title":"Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in mice","volume":"125","author":"Wang","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171116","article-title":"Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice","volume":"171","author":"Wang","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176775","article-title":"BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects","volume":"978","author":"Wang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0320","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awaa430","article-title":"Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-021-00779-7","article-title":"Dopamine, behavior, and addiction","volume":"28","author":"Wise","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0330","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13848","article-title":"Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid\/NPFF receptor agonist","volume":"32","author":"Xu","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1213\/ANE.0000000000006266","article-title":"OCP002, a mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception with Minimized Side Effects","volume":"136","author":"Xu","year":"2023","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0340","article-title":"Aprepitant Inhibits JNK and p38\/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s10020-022-00573-7","article-title":"Icaritin inhibits neuroinflammation in a rat cerebral ischemia model by regulating microglial polarization through the GPER-ERK-NF-\u03baB signaling pathway","volume":"28","author":"Yu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0355","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of Multifunctional and Orally active Cyclic Peptide Agonists of Opioid\/Neuropeptide FF Receptors that produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.775215","article-title":"Neurotensin Attenuates Nociception by Facilitating Inhibitory Synaptic Transmission in the Mouse Spinal Cord","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuroscience.2025.12.023_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173169","article-title":"Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia","volume":"880","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0370","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1021\/acs.jmedchem.1c01631","article-title":"Novel Cyclic Endomorphin Analogues with Multiple modifications and Oligoarginine Vector exhibit Potent Antinociception with Reduced Opioid-like Side Effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0375","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/bph.16287","article-title":"Novel endomorphin analogues CEMR-1 and CEMR-2 produce potent and long-lasting antinociception with a favourable side effect profile at the spinal level","volume":"181","author":"Zhang","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.023_b0380","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.peptides.2005.12.016","article-title":"Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation","volume":"27","author":"Zhao","year":"2006","journal-title":"Peptides"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:05:59Z","timestamp":1770224759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225011704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":76,"alternative-id":["S0306452225011704"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.023","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hybrid peptide BNT12 displays potent antinociception with limited opioid-like side effects at the spinal level","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}